3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
14
Active not recruiting
2
Unknown
1
Terminated
1
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Carcinoma, Non-Small-Cell Lung
43
Colorectal Neoplasms
22
Breast Neoplasms
22
Stomach Neoplasms
21
Neoplasms
17
Esophageal Squamous Cell Carcinoma
12
Neoplasm Metastasis
11
Nasopharyngeal Carcinoma
11
Lung Neoplasms
11
Rectal Neoplasms
9
Pancreatic Neoplasms
7
Colonic Neoplasms
7
Uterine Cervical Neoplasms
6
Esophageal Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
5
Ovarian Neoplasms
5
Osteosarcoma
5
Brain Neoplasms
5
Small Cell Lung Carcinoma
4
Recurrence
4
Glioblastoma
4
Gastrointestinal Neoplasms
4
Precision Cell Immunotherapy
3
Melanoma
3
Lymphoma, Non-Hodgkin
3
Lymphoma
3
Head and Neck Neoplasms
3
Gastrointestinal Diseases
3
Digestive System Neoplasms
3
Carcinoma, Ovarian Epithelial
3
Interventions
Paclitaxel
16
Carboplatin
15
Bevacizumab
7
Hyperthermic Intraperitoneal Chemotherapy
5
Cisplatin
4
Taxes
3
Gemcitabine
3
Cytoreduction Surgical Procedures
3
Chemotherapy, Adjuvant
3
oregovomab
2
niraparib
2
fluzoparib
2
Topotecan
2
ST 1481
2
Neoadjuvant Therapy
2
Methods
2
Immunohistochemistry
2
Ifosfamide
2
Gene Expression Profiling
2
Filgrastim
2
Educational Status
2
Early Intervention, Educational
2
Amplified Fragment Length Polymorphism Analysis
2
rucaparib
1
pembrolizumab
1
paclitaxel poliglumex
1
olaparib
1
navicixizumab
1
mirvetuximab soravtansine
1
liposomal doxorubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Fallopian Tube Neoplasms
×
Drug Therapy
×
Clear all
NCT04201561
2023-06-26
SELENIUM
Seoul National University Hospital
Phase 3
Unknown
68 enrolled